By: Jennifer Brown, Iowa Now
University of Iowa Holden Comprehensive Cancer Center and Mayo Clinic have received a five-year, $12.4 million grant renewal from the National Cancer Institute (NCI) to continue the Specialized Program of Research Excellence (SPORE) for lymphoma research. The renewal was based on a highly competitive process of peer review conducted by cancer researchers from across the country.
The University of Iowa–Mayo Clinic Lymphoma SPORE is a highly productive research collaboration focused on developing new approaches to the prevention, detection, and treatment of lymphoma. First funded in 2002 and competitively renewed in 2007, 2012, and now again in 2017, it is the nation’s longest-standing lymphoma SPORE and has now received more than $46 million from the NCI.
“We are thrilled to have our Lymphoma SPORE renewed for another five years,” says George Weiner, director and principal investigator of the SPORE at the University of Iowa and director of Holden Comprehensive Cancer Center. “It is particularly exciting to see advances we have made being applied worldwide to improve patient care.”
SPORE funds support four major research projects, four shared research cores, clinical trials, early pilot projects, and new investigators in lymphoma research taking place at Holden Comprehensive Cancer Center and Mayo Clinic Cancer Center.